This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Korea Institute of Science and Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Song Yi Koo
Introduction
Song Yi Koo is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of osteoarthritis. His innovative work has garnered attention for its potential to improve the quality of life for those suffering from this debilitating condition.
Latest Patents
Song Yi Koo holds a patent for a pharmaceutical composition aimed at preventing or treating osteoarthritis. The patent, titled "Pharmaceutical composition for prevention or treatment of osteoarthritis comprising obtusifolin, derivative thereof, or pharmaceutically acceptable salt thereof as active ingredient," highlights the use of obtusifolin and its derivatives as active ingredients. This composition is designed to inhibit factors that promote cartilage destruction and alleviate inflammatory responses, demonstrating significantly excellent effects in the treatment of osteoarthritis. He has 1 patent to his name.
Career Highlights
Koo is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the pharmaceutical sector. His work focuses on creating effective treatments that address the underlying causes of osteoarthritis, showcasing his commitment to advancing medical science.
Collaborations
Some of his notable coworkers include Hee Ju Lee and Eun Ha Lee, who contribute to the collaborative efforts in research and development at the Korea Institute of Science and Technology.
Conclusion
Song Yi Koo's innovative contributions to the field of pharmaceuticals, particularly in the treatment of osteoarthritis, highlight his dedication to improving healthcare solutions. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
